Abstract:Abstract— The enzyme 2′,3′‐cyclic nucleotide‐3′‐phosphohydrolase (CNP) has been assayed in fractions from a continuous sucrose density gradient zonal centrifugation of rabbit brain homogenates. Basic protein (BP) was also assayed by a radioimmunomethod. Fractions were examined by SDS‐polyacrylamide gel electrophoresis and by electron microscopy. These studies show that the major membrane fractions in the gradient differ greatly in the content of CNP and BP, and of high molecular weight proteins (HMW). The lightest membrane fractions contained numerous multilamellae, the highest content of BP and the lowest content of CNP and HMW, while the heaviest membrane fractions contained single membrane fragments and vesicles of unknown origin, the lowest content of BP and the highest content of CNP and HMW. The fraction containing the largest amount of membrane measured by turbidity, protein content, and water‐washed dry weight contained only half the CNP specific activity of a denser fraction in the gradient. CNP specific activity in the lightest fractions was insignificant compared to that of denser fractions. Thus, we conclude that this enzyme may be absent from the typical multilamellar myelin structures but present in the single‐membrane structures associated with myelin, such as the glial membrane and the paranodal segments of myelin adjacent to the axon. BP appears to occupy the opposite positions, highest in the multilamellae and lowest in the single‐membrane structures of myelin. These studies do not exclude the possibility that CNP may not be bound to myelin membranes, but rather to a membrane of different origin. Evidence that this enzyme is a myelin‐marker enzyme is circumstantial. Our evidence indicates the enzyme could be present either in a unique portion of myelin membranes or in another membrane structure.

Experimental study of a further attenuated live measles vaccine of the Sugiyama strain in Iran

Mitochondria in health, disease, and aging

Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets

Mitochondrial dysfunction: mechanisms and advances in therapy

Mitochondria: It is all about energy

Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment

Mitochondrial Dysfunctions: Genetic and Cellular Implications Revealed by Various Model Organisms

Post-translational modifications in mitochondria: protein signaling in the powerhouse

An Insight into the Approach Taken to Appurtenances Disorders Linked to Mitochondria

Mitochondria act as a key regulatory factor in cancer progression: current concepts on mutations, mitochondrial dynamics, and therapeutic approach

Mitochondria: A source of potential biomarkers for non-communicable diseases

LOCALIZATION OF 2′,3′‐CYCLIC NUCLEOTIDE‐3′‐PHOSPHOHYDROLASE OF RABBIT BRAIN BY SEDIMENTATION IN A CONTINUOUS SUCROSE GRADIENT 1

Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and Metabolism

Mitochondrial Dysfunction in Chronic Respiratory Diseases: Implications for the Pathogenesis and Potential Therapeutics

MOGE(S) nosology in low-to-middle-income countries

Mitochondria: In Sickness and in Health

Mitochondrial Dysfunction in Cardiac Disease: The Fort Fell

New Insights into Mitochondria in Health and Diseases

Mitochondrial dysfunction route as a possible biomarker and therapy target for human cancer

Mitochondria Related Cell Death Modalities and Disease

Role of Mitochondrial Dysfunctions in Neurodegenerative Disorders: Advances in Mitochondrial Biology